Pharmafile Logo

kelly smith

- PMLiVE

CDC provides $262.5m to create national network for infectious diseases

The OADMN aims to improve responses to outbreaks and prevent future pandemics

- PMLiVE

COVID-19 could be key in identifying viruses with pandemic potential

Researchers analysed major variants of concern, including the Omicron subvariants

- PMLiVE

Alzheimer’s Research UK launches ‘Change The Ending’ campaign

A survey revealed that 22% of 2,162 people were unaware of the impact dementia has on people’s everyday lives

- PMLiVE

Novo Nordisk Foundation commits €127m for new cell therapy facility

The new facility will help accelerate treatments for people living with chronic diseases

- PMLiVE

AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study

More than two million people worldwide are diagnosed with breast cancer every year

- PMLiVE

ICR and Merck renew strategic alliance for development of new cancer drugs

The latest agreement builds on 20 years of collaboration between the two partners

- PMLiVE

DeepMind’s AI tool classifies effects of mutations in genetic diseases

The Google unit's AlphaMissense tool has classified the effects of 71 million ‘missense’ mutations

- PMLiVE

CDC awards over $23m to Johns Hopkins Center for Health Security project

The five-year grant will be used to help launch a new epidemic preparedness project

Looking to start activity on a currently unpromoted pharmaceutical brand?

Looking to start activity on your current unpromoted brands in the UK? CHASE can fully manage the renewal of promotion! Get in touch with Richard Baderin on 0131 553 6644 or...

CHASE

https://youtu.be/866830208

Considering a portfolio review?

Are you considering a portfolio review for your established pharmaceutical brands? Wondering if you should put some activity behind them? At CHASE our experienced team will ensure you maximise your...

Wilmington Healthcare

Want the most from your Pharmaceutical portfolio?

Are you looking to maximise your mature pharmaceutical portfolio? With CHASE we can deliver innovative solutions to help your brands reach their potential! Get in touch with Richard Baderin on 0131...

CHASE

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links